Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects-Reference-Cited by-同舟云学术

Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects

Published:2010-03 Issue:2 Volume:79 Page:144-149
ISSN:0026-2862
Container-title:Microvascular Research
language:en
Short-container-title:Microvascular Research

Author:

Derosa Giuseppe,D'Angelo Angela,Salvadeo Sibilla A.T.,Ferrari Ilaria,Fogari Elena,Gravina Alessia,Mereu Roberto,Palumbo Ilaria,Maffioli Pamela,Randazzo Sabrina,Cicero Arrigo F.G.

Publisher

Elsevier BV

Subject

Cell Biology,Cardiology and Cardiovascular Medicine,Biochemistry

Reference33 articles.

1. Screening for diabetes (Position Statement);Diabetes Care,2001

2. Standards of medical care in diabetes;Diabetes Care,2007

3. Hyperglycaemia and mortality;Asadollahi;J. R. Soc. Med.,2007

4. Hyperglycaemia and cardiovascular disease;Bartnik;J. Intern. Med.,2007

5. Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events?;Bell;Endocr. Pract.,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial Dysfunction Is Associated with Decreased Nitric Oxide Bioavailability in Dysglycaemic Subjects and First-Degree Relatives of Type 2 Diabetic Patients;Journal of Clinical Medicine;2022-06-09

2. The function of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in several clinical conditions: Results and analysis of our survey;Clinical Hemorheology and Microcirculation;2021-09-23

3. Metabolic Actions of a Supplement of Ilex Paraguariensis (An Extract of the Leaf Standardized to 2% I-Deoxinojirimcina), White Mulberry and Chromium Picolinate in Nondiabetic Subjects with Dysglycemia: A Randomized Trial;Life;2021-07-18

Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patients

;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2019-09

5. Effects of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus After 7 Years of Therapy;The Journal of Clinical Pharmacology;2019-05-26